Comparison of the protein cargoes from indolent and progressive chronic lymphocytic leukemia (CLL) cells revealed that S100A9 protein levels in plasma EVs increased significantly with disease progression, thus contributing to disease progression via activation of the NF-KB pathway (41). Here, NFKB1 is linked to B-cell chronic lymphocytic leukemia.